MindWalk Holdings (HYFT) EBITDA (2020 - 2026)
MindWalk Holdings (HYFT) reported EBITDA of -$15168.0 for Q1 2026, down 100.1% year-over-year from $14.8 million in Q1 2025, and down 100.67% quarter-over-quarter from $2.3 million in Q4 2025.
MindWalk Holdings (HYFT) EBITDA (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of EBITDA data on file, last reported at -$15168.0 in Q1 2026.
- EBITDA for Q1 2026 came in at -$15168.0, down 100.1% year-over-year; the trailing twelve-month figure through Jan 2026 was -$1.2 billion (down 146.75% YoY), and the FY2025 annual result was -$20886.9, up 99.91% from the prior year.
- EBITDA fell to -$15168.0 in Q1 2026 per HYFT's latest filing, from $2.3 million in the prior quarter.
- Over five years, EBITDA peaked at $3.4 billion in Q3 2023 and troughed at -$1.2 billion in Q2 2025.
- A 5-year average of $281.6 million and a median of $705066.1 in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2025: EBITDA jumped 39321542.99% in 2023, then slumped 7128.34% in 2025.
- A 5-year view of EBITDA shows it stood at $4.0 million in 2022, then sank by 61.46% to $1.6 million in 2023, then rose by 12.35% to $1.7 million in 2024, then climbed by 29.05% to $2.3 million in 2025, then plunged by 100.67% to -$15168.0 in 2026.
- Business Quant data shows HYFT's EBITDA at -$15168.0 in Q1 2026, $2.3 million in Q4 2025, and -$2532.7 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -65.83 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | -15,167.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -15,167.99 |
| Oct 31, 2025 | 2.25 Mn |
| Jul 31, 2025 | -2,532.69 |
| Apr 30, 2025 | -1.19 Bn |
| Jan 31, 2025 | 14.83 Mn |
| Oct 31, 2024 | 1.75 Mn |
| Jul 31, 2024 | 2.54 Bn |
| Apr 30, 2024 | -16.47 Mn |
| Jan 31, 2024 | 2.28 Mn |
| Oct 31, 2023 | 1.55 Mn |
| Jul 31, 2023 | 3.44 Bn |
| Apr 30, 2023 | -6.39 Mn |
| Jan 31, 2023 | 705,066.09 |
| Oct 31, 2022 | 4.03 Mn |
| Jul 31, 2022 | -8,737.85 |
| Apr 30, 2022 | -3.38 Mn |
| Jan 31, 2022 | -3,073.42 |
| Oct 31, 2021 | -4,477.52 |
| Jul 31, 2021 | -2,721.96 |
| Apr 30, 2021 | -2.46 Mn |